<DOC>
	<DOCNO>NCT01556659</DOCNO>
	<brief_summary>Left Ventricular ( LV ) thrombus formation witness least 10 % patient ST segment elevation myocardial infarction ( STEMI ) . It fear complication since might increase risk thrombo-embolic event , include stroke . Guidelines recommend vitamin K antagonist treatment patient . However patient STEMI nowadays undergo primary percutaneous coronary intervention ( PCI ) coronary stent placement consequently require dual anti-platelet therapy ( ascal P2Y12 inhibitor ) prevent stent thrombosis . Consequently , STEMI patient LV thrombus currently treat triple antithrombotic therapy ( aspirin , P2Y12 inhibitor , e.g . clopidogrel ( 75 mg/d ) vitamin K antagonist ) . Patients treat triple antithrombotic therapy subject strongly increase bleed risk yearly incidence 3.7 % dual anti-platelet therapy compare 12 % triple antithrombotic therapy . About 10 % bleeding cerebral . The mortality haemorrhagic stroke 25 % . A recent retrospective analysis show beneficial effect addition vitamin K antagonist dual anti-platelet therapy prevent stroke . If vitamin K antagonist-therapy could omit , morbidity mortality due post-PCI bleeding decrease . Therefore , randomize trial warrant address issue . Design : A multicenter , prospective , randomize , two non-inferiority trial . The objective study determine randomize fashion risk benefit addition vitamin K antagonists dual anti-platelet therapy dual anti-platelet therapy patient PCI-treated STEMI LV thrombus formation baseline echocardiography baseline Magnetic Resonance Imaging ( MRI ) .</brief_summary>
	<brief_title>LV Thrombus After Acute AMI : A Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Acenocoumarol</mesh_term>
	<criteria>Suspected Left Ventricular thrombus echocardiography routine Magnetic Resonance Imaging Ongoing treatment dual antiplatelet therapy accord ESC/ACCAHA guideline time randomization . Younger 18 Clinically hemodynamically unstable Treatment vitamin K antagonist prior PCI expect indication vitamin K antagonist treatment ( e.g . atrium fibrillation ) within next 6 month Previous stroke transient ischemic attack Scheduled major surgery ( include Coronary Artery Bypass Grafting ) course study Active bleeding high risk bleed contraindicate treatment vitamin K antagonists Contraindication vitamin K antagonist treatment Chronic treatment NSAIDs COX2 inhibitor 4 day per week anticipate continue study Congenital cardiac disease Presence supraventricular ventricular arrhythmia Expected candidate ICD implantation next 6 month Severe renal impairment ( estimate CrCl calculate CockcroftGault equation 5 30mL/min ) Known symptomatic brain disease ( brain tumor ) Women pregnant . Any contraindication ContrastEnhanced Magnetic Resonance Imaging ( pacemaker , cerebrovascular clip , know contrast allergy , claustrophobia ) Followup impossible ( example fix abode )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Left ventricular thrombus</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Anticoagulation</keyword>
</DOC>